James Lee
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 15
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 6
- Immunology 10
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 3
- Co-authors
- Michel SadelainRenier J. BrentjensHollie J. PegramErik HaymanThomas F. TedderGavin H. ImperatoJeffrey A. BluestoneArabella Young
- Journals
- The Journal of Immunology (2 papers)Cancer (1 paper)Nature Medicine (1 paper)Cellular and Molecular Immunology (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesAustraliaTaiwan
In The Last Decade
James Lee
23 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.4k
- Immunology 738
- Genetics 473
- Nephrology 109
- Cancer Research 208
Countries citing papers authored by James Lee
This map shows the geographic impact of James Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lee more than expected).
Fields of papers citing papers by James Lee
This network shows the impact of papers produced by James Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lee. The network helps show where James Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 83 | |
| 4 | 2021 | 84 | |
| 5 | 2020 | 198 | |
| 6 | 2020 | 9 | |
| 7 | 2019 | 19 | |
| 8 | 2018 | 57 | |
| 9 | Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors Hit paper breakdown → | 2018 | 412 |
| 10 | 2015 | 0 | |
| 11 | 2013 | 115 | |
| 12 | 2013 | 21 | |
| 13 | 2013 | 15 | |
| 14 | 2009 | 99 | |
| 15 | 2009 | 173 | |
| 16 | Supplementary Materials for Kinome siRNA Screen Identifies Regulators of Ciliogenesis and Hedgehog Signal Transduction | 2008 | 13 |
| 17 | 2007 | 112 | |
| 18 | 2007 | 10 | |
| 19 | Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas. | 2002 | 28 |
| 20 | 1999 | 197 |
About James Lee
James Lee is a scholar working on Oncology, Immunology, Cancer Research, Cell Biology and Immunology and Allergy, having authored 24 papers that have together received 2.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (3 papers), Virus-based gene therapy research (2 papers), Microtubule and mitosis dynamics (2 papers) and Chromosomal and Genetic Variations (2 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (738 citations), Genetics (473 citations), Nephrology (109 citations) and Cancer Research (208 citations). James Lee has collaborated with scholars based in United States, Australia and Taiwan. Frequent co-authors include Michel Sadelain, Renier J. Brentjens, Hollie J. Pegram, Erik Hayman, Thomas F. Tedder, Gavin H. Imperato, Jeffrey A. Bluestone, Arabella Young, Vishva M. Dixit and Adil Daud. Their work appears in journals such as The Journal of Immunology, Cancer, Nature Medicine, Cellular and Molecular Immunology and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.